Literature DB >> 2550410

Cytomegalovirus infection in the acquired immune deficiency syndrome.

A J Pinching1.   

Abstract

CMV disease is a major problem in AIDS, though with a different profile from that seen in other immunosuppressed patients. The novel treatments, ganciclovir and phosphonoformate, have a major role in the management of such infections, but maintenance therapy is often required. Optimal maintenance regimens have yet to be established, especially where zidovudine is also being used.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550410     DOI: 10.1093/jac/23.suppl_e.31

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

Review 1.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 2.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection.

Authors:  R Enzensberger; W Braun; C July; E B Helm; H W Doerr
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

4.  Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus.

Authors:  R W Flø; G Haukenes; A Nilsen; R Skjaerven; M Forsgren; T E Fehniger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

Review 5.  Adrenal infections.

Authors:  William F Paolo; Joshua D Nosanchuk
Journal:  Int J Infect Dis       Date:  2006-02-17       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.